Navigation Links
Chancroid Vaccine shows Promise for Control of AIDS

Vaccine against Haemophilus ducreyi which causes chancroid has been shown to prevent the transmission of HIV as well. Experiments conducted in pigs with this vaccine have shown to prevent or reduce the painful open sores of chancroid on the genitals // and thereby reduce the transmission of HIV,

Chancroid is a highly contagious STD that is common in Africa and today becoming more common in the United States as well. Antibiotics can be used to effectively treat chancroid. If left untreated, chancroid can lead to the transmission of HIV.

Lead researcher Dr. Christopher Elkins at the University of North Carolina in Chapel Hill, and his associates purified a part of the bacteria, Haemophilus ducreyi and vaccinated pigs on days 1, 21, and 42. The researchers tested the pigs three weeks later with Haemophilus ducreyi.

The results of their research were published in the journal Infection and Immunity. Although the vaccinated pigs developed the characteristic chancroid lesions, it was found that these lesions were smaller 7 days later and less inflamed compared with the lesions in pigs, vaccinated with a placebo.

In addition it was found that lesions of the vaccinated pigs were sterile while biopsies of all the 17 placebo-vaccinated pigs showed the presence of viable Haemophilus ducreyi. The blood of the vaccinated pigs also had high levels of antibodies against the chancroid bug.

Elkins explained that the prevention of chancroid lesions could help to reduce transmission of HIV because 'high concentrations' of HIV-susceptible cells are often present in chancroid ulcers.


'"/>




Page: 1

Related medicine news :

1. Chancroid Vaccine Holds Promise In Reducing HIV Transmission
2. Vaccine to quit smoking?
3. First Vaccine Designed for Africa Cleared for Testing in Humans
4. Vaccine for Alzheimer’s diseas
5. Health Officials Recommend Flu Vaccine
6. Smallpox Vaccine May Help Fight Cervical Cancer
7. Panacea Biotech To Market Anthrax Vaccine
8. New Prostate Cancer Vaccine Shows Promise
9. Drug Firm Offers to Donate Smallpox Vaccine
10. Vaccine guards against shingles
11. Vaccine for septic conditions
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... ... As health professionals work to improve their approach to healthcare, there is ... than filling out a survey; in many cases health professionals and patients are working ... and research on the importance of active engagement with patients and members of the ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and ... Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD ... that can be easily incorporated into liquid products, while reducing costs to end users. ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “America On The ... identity. “America On The Brink” is the creation of published author, William Nowers. ... great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/19/2017)... venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound ... ... Jim Bertolina, PhD ... Tom Tefft ... device executive Josh Stopek , PhD, who has led R&D and business development teams ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
Breaking Medicine Technology: